I am a surgical oncologist dedicated to the care of patients with malignancies of the liver and biliary tract. My research focus is optimizing patient selection for hepatic resection using molecular markers, mutational profiles, and response to systemic therapy. I am co-principal investigator on an R01 grant awarded to MD Anderson and Memorial Sloan-Kettering Cancer Center, entitled Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver Metastases. I am Core Leader on a Specialized Programs of Research Excellence (SPORE) grant on hepatocellular carcinoma awarded to MD Anderson. As a member of The Pathology and Biobanking Core, I direct the primary liver cancer tissue bank. I am senior author on the first study in the literature on genetic alterations in resected multifocal intrahepatic cholangiocarcinoma. The results demonstrated that genomic profiles are concordant across all tumors in an individual patient, suggesting that multifocal tumors in intrahepatic cholangiocarcinoma represent monoclonal metastatic seeding.